EddyCHsuehMD
General Surgery • Saint Louis, MOSurgical Oncology (Other than Breast)
Professor in the Department of Surgery, Division of General Surgery, at Saint Louis University School of Medicine
Dr. Hsueh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3655 Vista Ave
Saint Louis, MO 63110Phone+1 314-977-4440Fax+1 314-977-1630
Education & Training
SUNY Downstate Health Sciences UniversityResidency, Surgery, 1991 - 1996
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1996 - 2026
MO State Medical License 2003 - 2025- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 17 citationsOptimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test.Abel Jarell, Brian R Gastman, Larry D Dillon, Eddy C Hsueh, Sebastian Podlipnik
Journal of the American Academy of Dermatology. 2022-12-01 - 18 citationsOxidized Lipoproteins Promote Resistance to Cancer Immunotherapy Independent of Patient ObesityNiloufar Khojandi, Lindsey M. Kuehm, Alexander Piening, Maureen J. Donlin, Eddy C. Hsueh
Cancer Immunology Research. 2021-02-01 - 255 citationsTumor Microenvironments Direct the Recruitment and Expansion of Human Th17 CellsXinming Su, Jian Ye, Eddy C. Hsueh, Yanping Zhang, Daniel F. Hoft
Journal of Immunology. 2010-02-01
Press Mentions
Newly Published Independent, Prospective Study Reinforces Prognostic Accuracy of DecisionDx-Melanoma in Cutaneous MelanomaApril 11th, 2019
Grant Support
- Enhancement Of Immunogenicity Of Human Melanoma VaccineNational Cancer Institute2003–2005
- Enhancement Of Immunogenicity Of Human Melanoma VaccineNational Cancer Institute2000–2003
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
